Related Experiment Videos
[Role of ambulatory ECG in a cardiology department]
Insights
Ambulatory electrocardiographic monitoring, or Holter monitoring, aids in diagnosing heart conditions and managing treatment. Optimal Holter monitoring duration should be individualized based on patient symptoms and cardiac status for cost-effective care.
Area of Science:
- Cardiology
- Medical Devices
- Diagnostic Tools
Context:
- Ambulatory electrocardiographic monitoring, specifically Holter monitoring (H), is a crucial tool for diagnosing and managing cardiac arrhythmias and ischemic heart disease.
- It is widely applied in evaluating patients with conditions such as myocardial infarction, angina pectoris, and various cardiomyopathies.
Purpose:
- To explore the established and potential roles of Holter monitoring in clinical practice.
- To investigate its utility in prognosis, evaluating drug therapy efficacy, and identifying potential proarrhythmic effects or withdrawal syndromes.
- To propose individualized Holter monitoring duration based on patient-specific factors.
Summary:
- Holter monitoring is valuable for diagnosing and managing various heart conditions and assessing treatment outcomes.
- While its role in prognosis is not fully established, it can reveal drug efficacy and adverse effects like proarrhythmia.
- Optimal monitoring duration requires patient-specific adjustment considering symptoms, cardiac condition, and monitoring goals.
Impact:
- Holter monitoring, when appropriately applied, can be a cost-effective diagnostic tool.
- It has the potential to prevent unnecessary hospitalizations by providing critical diagnostic information.
- Individualized monitoring protocols can enhance diagnostic yield and therapeutic management.
Abstract:
Ambulatory electrocardiographic monitoring has become an important clinical tool for the diagnosis and management of patients with symptoms suggesting cardiac arrhythmias or ischemic heart disease. Holter monitoring (H) is widely used in the evaluation of patients with recent myocardial infarction, angina pectoris, hypertrophic cardiomyopathy, dilated cardiomyopathy, long QT syndrome, sinus node dysfunction. The role of H monitoring in defining prognosis in many of these heart disease is not well established. Holter monitoring is also used to evaluate the results of antiarrhythmic and antianginal drug therapy. Application of quantitative H monitoring to define drug efficacy has revealed that antiarrhythmic drugs may have a proarrhythmic effect and that a withdrawal syndrome can follow the abrupt cessation of antianginal and antiarrhythmic drugs. There are no consistent data about the optimal duration of monitoring to detect and quantify ventricular arrhythmias and ischemic attacks. We think that the appropriate duration of monitoring must be adjusted to the single patient, considering: a) the frequency and severity of symptoms; b) the cardiac lesion (s) and functional class; c) the goal of H. When used appropriately H can be a cost-effective tool and may prevent hospitalizations.